Form 4: Ardent Health Partners Executive Reports Stock Transactions

David Schultz, President of Hospital Operations at Ardent Health Partners, reports the acquisition and disposal of company stock.

Summary

• David Schultz, President of Hospital Operations at Ardent Health Partners, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
• On March 31, 2025, 1,825 shares of common stock were withheld for payment of taxes upon vesting of restricted stock units at a price of $13.75 per share, leaving him with 37,187 shares.
• On April 1, 2025, Mr. Schultz acquired 26,985 restricted stock units, bringing his total holdings to 64,172 shares.
• These restricted stock units vest in three substantially equal installments on each anniversary of April 1, 2025, contingent upon his continued service with the Issuer.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock transactions. The acquisition of restricted stock units can be seen as a slightly positive sign of confidence.

Positives

• The acquisition of restricted stock units indicates confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock units suggests a multi-year commitment from the executive.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders.

Stakeholder Impact

• The stock transactions may have a minor impact on shareholder sentiment.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Transaction, Restricted Stock Units, Ardent Health Partners, David Schultz